The integration of cytokines into stem cell and organoid research has significantly advanced drug discovery by enabling more ...

Immunotherapy holds enormous promise to create a new outlook of cancer therapy ... The 20kDa PEG conjugated oAd dramatically reduced liver accumulation and hepatotoxicity by systemic administration.

Taken together, PMI’s preclinical and clinical data constitute a concerning pattern of possible hepatotoxicity, especially considering the short period of exposure. These findings indicate IQOS may ...

Methotrexate also can cause hepatotoxicity and neutropenia. In 2012, the FDA approved glucarpidase as an antidote to reduce methotrexate levels. However, its use in practice has varied due to high ...

Medicare covers immunotherapy treatment for cancer. Out-of-pocket costs will vary, depending on the Medicare plan a person has and whether or not they have supplemental insurance. If a person has ...

"The CARES-oo5 study showed a clinically meaningful and statistically significant improvement in the primary endpoint of PFS for unresectable HCC who received TACE plus immunotherapy-based ...

A research team made a pivotal discovery in the field of cancer immunotherapy. The team identified a specific population of immune cells that play a critical role in successful treatment of ...

The number of cancer cases being diagnosed in India every year is a whopping 14 lakh. Immunotherapy research and treatment in the country has come a long way, making it an effective treatment ...

Get Instant Summarized Text (Gist) A clinical trial demonstrated that combining chemotherapy with immunotherapy significantly improves treatment outcomes for diffuse large B-cell lymphoma (DLBCL ...

With that being said, investigators then evaluated the effect of glucarpidase on outcomes like kidney recovery, neutropenia, hepatotoxicity, mucositis, and mortality among patients with MTX-associated ...